The purpose of this clinical trial is to evaluate the effectiveness and safety of the multifocal Artiflex Presbyopic (Artiplus) intraocular lens.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Improvement in monocular and binocular uncorrected near visual acuity (UNVA)
Timeframe: 3 years
Improvement in monocular and binocular corrected near visual acuity (CNVA)
Timeframe: 3 years
Improvement in monocular and binocular distance corrected near visual acuity (DCNVA)
Timeframe: 3 years
Improvement in monocular and binocular uncorrected intermediate visual acuity (UIVA)
Timeframe: 3 years
Improvement in monocular and binocular distance corrected intermediate visual acuity (DCIVA)
Timeframe: 3 years
Improvement in monocular and binocular uncorrected distance visual acuity (UDVA)
Timeframe: 3 years
Improvement in monocular and binocular corrected distance visual acuity (CDVA)
Timeframe: 3 years
Defocus evaluation
Timeframe: 3 years
Predictability of the manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Predictability of the manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Predictability of the manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Stability of manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Stability of manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Stability of manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Satisfaction questionnaire
Timeframe: 3 years
Endothelial cell density
Timeframe: 3 years
Endothelial cell density
Timeframe: 3 years
Endothelial cell density
Timeframe: 3 years
Adverse event (AEs) / complication rates
Timeframe: 3 years